ACQUISITIONS - MedTech Group (Details) - USD ($) |
Oct. 13, 2014 |
Dec. 31, 2016 |
Dec. 31, 2015 |
---|---|---|---|
Allocation of net purchase price to assets acquired and liabilities assumed | |||
Goodwill | $ 222,843 | $ 4,482,845 | |
Medtech Group | |||
Allocation of net purchase price to assets acquired and liabilities assumed | |||
Intangible assets | $ 12,800,000 | ||
Goodwill | 2,700,000 | ||
Net purchase price | $ 15,500,000 | ||
Medtech Group | Interest Sale Agreement | |||
Acquisitions | |||
Ownership interest held (as a percent) | 100.00% | ||
Consideration paid | $ 1,000,000 | ||
Promissory note issued | 9,000,000 | ||
Outstanding amount after renegotiation | 6,250,000 | ||
Debt reduction available upon early repayment | $ 750,000 |
X | ||||||||||
- Definition Amount of debt extinguished, contingent upon the satisfaction of agreed-upon conditions. No definition available.
|
X | ||||||||||
- Definition The equity interest of controlling shareholders, partners or other equity holders in an entity. No definition available.
|
X | ||||||||||
- Definition The fair value of notes issued after the debtor and creditor agree to new payment terms. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of intangible assets, excluding goodwill, acquired at the acquisition date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The fair value of notes issued in noncash investing and financing activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|